Skip to content

News

Imbed Biosciences Wins a $2M Award From the U.S. Army to Prevent Combat Wound Infections

Madison, WI — 10 November 2021 – Imbed Biosciences, Inc. announced today that it has been awarded a contract for $1,999,481 by the U.S. Army Medical Research and Development Command’s (USAMRDC) Military Infectious Diseases Research Program (MIDRP) to accelerate clinical development of an antibiofilm version… Read More »Imbed Biosciences Wins a $2M Award From the U.S. Army to Prevent Combat Wound Infections

Microlyte® SURGICAL Associated with Positive Outcomes in Prospective Clinical Case Series in Patients at Risk for Surgical Site Infection

Madison, WI, October 4, 2021 – Imbed Biosciences, Inc. (Imbed), a privately held biotech company emerging as a leader in advanced wound care, announced today the results of a prospective clinical evaluation of its next-generation wound Matrix, Microlyte® SURGICAL, in diabetic patients undergoing foot and… Read More »Microlyte® SURGICAL Associated with Positive Outcomes in Prospective Clinical Case Series in Patients at Risk for Surgical Site Infection

Microlyte® Matrix and Microlyte® Surgical featured in clinical research presented at SAWC

Madison, WI, October 12th, 2021 – Imbed Biosciences is proud to announce that research conducted using Microlyte Matrix and Microlyte Surgical will be presented in a panel discussion at SAWC, a national wound healing conference. Imbed Biosciences announced today that clinical results documenting the use… Read More »Microlyte® Matrix and Microlyte® Surgical featured in clinical research presented at SAWC

Imbed Biosciences Wins 2020 Defense TechConnect Innovation Award and Will Pitch Microlyte® Wound Matrix Technology At Defense TechConnect Summit

MADISON, WI, NOVEMBER 16, 2020 Imbed Biosciences, Inc. (Imbed), a privately held biotech company emerging as a leader in advanced wound care, received a 2020 Defense TechConnect Innovation Award to pitch its Microlyte® Wound Matrix technology during the 2020 Virtual TechConnect Summit, November 17-19, 2020. The annual TechConnect Defense Innovation… Read More »Imbed Biosciences Wins 2020 Defense TechConnect Innovation Award and Will Pitch Microlyte® Wound Matrix Technology At Defense TechConnect Summit

Microlyte Matrix Featured in Clinical Research Presented at National Wound Healing Conference

MADISON, WI, OCTOBER 12, 2019 Imbed Biosciences, a developer of advanced biomaterials and soft tissue repair devices, announced today that clinical results documenting the use of its flagship product, Microlyte® Matrix resorbable antimicrobial wound matrix, will be presented at the Fall Symposium on Advanced Wound… Read More »Microlyte Matrix Featured in Clinical Research Presented at National Wound Healing Conference